Skip to main content

Table 1 Demographic characteristics of 3674 patients admitted to the hospital with confirmed COVID-19, and drugs administered to them during their entire hospitalization (Hospital das Clínicas, University of Sao Paulo, Brazil—30 March–30 August, 2020)

From: Correlating drug prescriptions with prognosis in severe COVID-19: first step towards resource management

Demographic data

N: 3674

Female sex, n (%)

1682 (46%)

Age (years)

 

   Mean (SD)

58 (17.9)

   Median (range)

60 (13–101)

Days of hospital stay

 

   Mean (SD)

14.6 (1.3)

   Median (range)

10.3 (1–153)

Admission directly to an ICU, n (%)

1475 (40%)

Deaths

1169 (32%)

Number of prescriptions evaluated

821,532

Drugs

N (%)

   Anticoagulants

3445 (94)

   Antibiotics

3300 (90)

   Antipyretics

3010 (82)

   Proton pump inhibitor

2556 (70)

   Sedatives

2002 (54)

   Electrolytes

1958 (53)

   Furosemide

1916 (52)

   Insulin

1700 (46)

   IV corticosteroids

1652 (45)

   Vasoactive drugs

1572 (43)

   Antipsychotic

1458 (40)

   Bisacodyl

1360 (37)

   Neuromuscular blocking agents

1278 (35)

   Oral corticosteroids

1215 (33)

   Antiviral drugs

1160 (32)

   Ondansetron

849 (23)

   Metoclopramide

819 (22)

   Anticonvulsive drugs

751(20)

   Hydrochlorothiazide

739 (20)

   Statins

728 (20)

   Anti-hypertensive calcium channel blocker

660 (18)

   Acetylsalicylic acid

660 (18)

   Methadone

629 (17)

   Blood components

622 (17)

   Angiotensin-converting enzyme inhibitors

519 (14)

   Angiotensin receptor blockers

508 (14)

   Vitamins

505 (14)

   Atropine

503 (14)

   Salbutamol

488 (13)

   Scopolamine

447 (12)

   Amiodarone

431 (12)

   Dimethicone

431 (12)

   Anti-hypertensive beta-blocker

399 (11)

   Levothyroxine

392 (11)

   Anti-hypertensive vasodilator

352 (10)

   Ivermectin

312 (8)

   Hydroxychloroquine

43 (1)

   Tocilizumab

3 (0.1)

  1. SD standard deviation, ICU intensive care unit, IV intravenous